2011-2012

Written By Brittan Goetz

  • Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease. Pharmacol Revs 64:972-1003, 2012.  https://pharmrev.aspetjournals.org/content/64/4/972

  • Triterpenoid modulation of IL-17 and Nrf-2 expression ameliorates neuroinflammation and promotes remyelination in autoimmune encephalomyelitis.  Sci Rep 1:201-11, 2011. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242013/

  • Proteomic analysis shows synthetic oleanane triterpenoid binds to mTOR. PLoS ONE 6(7):e22862. 2011.   https://pubmed.ncbi.nlm.nih.gov/21818401/

  • Neuroprotective effect of Nrf2/ARE activators, CDDO-ethylamide and CDDO-trifluoroethylamide in a mouse model of amyotrophic lateral sclerosis. Free Radic Biol Med 51:88-96, 2011.  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109235/

  • New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress. J Nat Prod 74:537-545, 2011  https://pubmed.ncbi.nlm.nih.gov/21309592/

Brittan Goetz http://www.brittanbaylygoetz.com
Previous

2013-2022
Next

1999-2000